Abdulrahman Nasiri: Alloimmune Thrombocytopenia After Liver Transplantation from Donor with ITP
Abdulrahman Nasiri, Assistant Professor of Medicine and Hematology at Imam Mohammad Ibn Saud Islamic University, shared on LinkedIn:
”I am pleased to share the publication of our recent case report in Hematology:
“Transplantation-mediated alloimmune thrombocytopenia following liver transplantation from a donor with ITP: a case report and review of the literature.”
This report describes a rare but serious complication of liver transplantation, where donor derived immune cells caused profound thrombocytopenia in the recipient.
Our case highlights that intensive medical therapy alone can achieve full recovery and avoid the need for retransplantation, an important insight for transplant teams worldwide.
I am deeply grateful to my colleagues for their dedication and to Dr. Hazzaa Alzahrani for his invaluable guidance and supervision throughout this work.”
Read the full article here.
Article: Transplantation-mediated alloimmune thrombocytopenia following liver transplantation from a donor with ITP: a case report and review of the literature
Authors: Ahmed Bin Salman, Mostafa F. Mohammed Saleh, Abdulrahman Nasiri, Hazza Alzahran
Stay informed on the latest scientific advances in the field of platelet disorders with Hemostasis Today.
-
Nov 8, 2025, 05:31Phenotyping of Human Platelets by Daisie Yates
-
Nov 8, 2025, 04:35Inaugural Women In Hematology US Focus Meeting 2025 Officially Commenced
-
Nov 7, 2025, 06:59Stephen Cornelissen is Celebrating an Extraordinary Milestone at Australian Red Cross Lifeblood
-
Nov 7, 2025, 06:56Reza Shojaei on Leadership in the Blood and Plasma Sector
-
Nov 7, 2025, 06:52Rachel Margolis-Goodman Announces Groundbreaking Expension of Versiti Blood Research Institute
-
Nov 7, 2025, 06:46What’s New in HIT from THANZ Webinar Series
-
Nov 7, 2025, 03:30Abdallah Othman About Cardiac Vasculature
-
Nov 7, 2025, 03:29Aabha Divya: Thrilled to Share Our Latest Publication in Annals of Thoracic Surgery Short Reports!
-
Nov 7, 2025, 03:28Shantel Holcomb: Boston Scientific is Investing in Innovative Solutions to Improve Outcomes for Patients With CAD